Fenofibric Acid
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for accurate information.
Fenofibric Acid Product Information
Fenofibric Acid is listed under Metabolite and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Fenofibrate. The product is supplied by Clearsynth under CAT No. CS-O-10312.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
Fenofibric Acid
CAS No.
42017-89-0
CAT No.
CS-O-10312
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C17H15ClO4
Molecular Weight
318.75
Category
API Family
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for accurate information.
Description
Regulatory Description
Fenofibric Acid is supplied with detailed characterization data compliant with regulatory guideline. Fenofibric Acid can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Fenofibrate.
Overview
Fenofibric acid is the active metabolite of Fenofibrate . Increases Apolipoprotein A-I?Mediated High-Density Lipoprotein Biogenesis by enhancing transcription of ATP-Binding cassette transporter A1 gene in a liver X receptor?dependent manner.
Synonyms
Fenofibric Acid
Application Notes
Fenofibric acid is the active metabolite of Fenofibrate . Increases Apolipoprotein A-I?Mediated High-Density Lipoprotein Biogenesis by enhancing transcription of ATP-Binding cassette transporter A1 gene in a liver X receptor?dependent manner.
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.